Advocacy Group Petitions FDA to Ban Direct-to-Consumer Prescription Drug Advertising Nationwide

Summary

Public Citizen has formally petitioned the FDA to prohibit direct-to-consumer advertising for prescription drugs, citing concerns over inflated costs and clinical misinformation. This move threatens a primary marketing channel for pharmaceutical companies targeting women across hormonal and chronic conditions.

The action lands in Therapeutics and Care Delivery and shifts the ground rules for operators, payers, and clinical pathways. Coverage, reimbursement, and go-to-market friction in this lane typically re-rate on this kind of move.

Sources

• OVUM Primary source